Drugs / FSME-IMMUN Vaccine
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04573205 | Jan 2024 | tick-borne encephalitis | Region Örebro County | Unknown | No outcome recorded |
| Phase 4 | NCT04017052 | Apr 2015 → Feb 2020 | tick-borne encephalitis | Medical University of Vienna | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FSME-IMMUN Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04017052 ↗ |
| Known as | FSME Immun | “booster vaccination with TBE vaccine "FSME Immun"” NCT04017052 ↗ |
| Modality | Vaccine | “revaccinated 37 obese individuals and 36 normal-weight controls with a licensed TBE vaccine” PMID 32528467 ↗ May 2020 |
| Route | Intramuscular | “Booster with TBE vaccine (i.m.) FSME Immun” NCT04017052 ↗ |